|
Read Articles -
Complications in Pregnancy Fun Ways to Announce Your Pregnancy Preparing the kids for Pregnancy Morning Sickness During Pregnancy |
HIV/AIDS during Pregnancy
According to the March of
Dimes, there are an estimated 120,000 to 160,000 women in the United
States who have been infected with HIV. About 6,000 to 7,000 of women
infected with HIV give birth annually. Since the beginning of the HIV/AIDS
epidemic, approximately 15,000 children in the United States have been
infected with HIV and 3,000 children have died. About 90 percent of those
were infected with the virus during pregnancy or birth. HIV (Human Immunodeficiency Virus) is a virus that
causes AIDS (Acquired Immunodeficiency Syndrome). A person may be “HIV
positive” but not have AIDS. An HIV infected person may not develop AIDS
for 10 years or longer. A person who is HIV positive can transmit the
virus to others when infected blood, semen or vaginal fluids come in
contact with broken skin or mucus membranes. If a woman is infected with HIV, her risk of
transmitting the virus to her baby is reduced if she stays as healthy as
possible. According to the March of Dimes, new treatments can reduce the
risk of a treated mother passing HIV to her baby to a 2 percent or less
chance. Women who are planning on becoming pregnant or who are
pregnant should be tested for HIV as soon as possible. The woman’s partner
should also be tested. The March of Dimes recommends that all women of
childbearing age who may have been exposed to HIV should be tested before
becoming pregnant. Women who have not been tested before becoming pregnant
should be offered counseling and voluntary testing during pregnancy. Women
who have not been tested during pregnancy can be screened during labor and
delivery with rapid tests which can produce results in less than one hour.
This allows for treatment to protect the baby should the results be
positive. In most cases, HIV will not cross through the placenta
from mother to baby. If the mother is healthy in other aspects, the
placenta helps provide protection for the developing infant. Factors that
could reduce the protective ability of the placenta include in-uterine
infections, a recent HIV infection, advanced HIV infection or
malnutrition. A baby can become infected with HIV in the womb, during
delivery or while breast-feeding. If the mother does not receive
treatment, 25 percent of babies born to women with HIV will be infected by
the virus. With treatment that percentage can be reduced to less than 2
percent, according to the March of Dimes. A multi-care approach is the most effective way for
pregnant women with HIV infection to have a healthy pregnancy and
delivery. This approach will address the medical, psychological, social
and practical challenges of pregnancy with HIV. While the woman’s
pregnancy is being managed by a health care provider and HIV specialist,
she may also receive assistance from a social services agency to help her
with housing, food, child care and parenting concerns. She would also be
receiving counseling support for herself and her partner. Additional care
could be provided in the areas of substance abuse and lifestyle
counseling. This team effort will provide the best prenatal care plan for
women infected with HIV. Many of these services could continue during her
postpartum period. The United States Public Health Service recommends that
HIV-infected pregnant women be offered a combination treatment with
HIV-fighting drugs to help protect her health and to help prevent the
infection from passing to the unborn baby. If no preventative steps are taken, the risk of HIV transmission during
childbirth is estimated to be 10-20%. The chance of transmission is even
greater if the baby is exposed to HIV-infected blood or fluids. Health
care providers should avoid performing amniotomies (intentionally
rupturing the amniotic sac to induce labor), episiotomies and other
procedures that expose the baby to the mother’s blood. The risk of
transmission increases by 2% for every hour after membranes have been
ruptured. A 1994 study by the National Institutes of Health found that giving ZDV to
an HIV-positive pregnant woman during her pregnancy and to her baby
(within 8-12 hours of birth) decreased the risk of passing the infection
on to the baby by 66%. The baby should be treated with ZDV for the first
six weeks of life. Eight percent of babies of women treated with ZDV
became infected, compared with 25 percent of babies of untreated women. No
significant side effects of the drug have been observed other than a mild
anemia in some infants that cleared up when the drug was stopped.
Follow-up studies show that the HIV-negative treated babies continued to
develop normally. About 15% of newborns born to HIV-positive women will become infected if
they breastfeed for 24 months or longer. |
||
|
|